Novel Therapeutic Targets

Autoimmunity results from a break in self-tolerance involving humoral and/or cell-mediated immune mechanisms. One pathological consequence of a failure in central and/or peripheral tolerance is the generation of autoantibodies and subsequent formation of complement-fixing immune complexes that contribute to tissue damage. Prevailing pharmacological strategies for treating autoimmune diseases involve the use of broad-acting immunosuppressants that with long term use have associated toxicities. 

  • Drug Delivery Systems
  • Membrane Proteins/Antagonists & Inhibitors
  • Tumor Necrosis Factor-alpha/Metabolism

Novel Therapeutic Targets Conference Speakers

Recommended Sessions

Related Journals

Are you interested in